BICLUSTER_ID : UPREG-28
PATHOGENS /3/ : listeria monocytogenes,streptococcus pneumoniae,yersinia enterocolitica
TARGETS /13/ : P4HA1, NFKB1, MMP12, NP, SERPINB2, GSK3B, PDGFRA, IL6, PTGS2, AMPD3, CASP1, PIM1, TXNRD1
Gene SetLeading Edge Genes
NETPATH IL 1 PATHWAY UPNFKB1, MMP12, LIF, CXCL1, NP, HBEGF, SERPINB2, IL6, PTGS2, AMPD3, ZFP36, MT2A, CXCL2, TXNRD1, PTX3
NETPATH TNF ALPHA PATHWAY DOWNDDX5, SH3BP4, SURB7, EXT1, CXCL2, IER3, KLF6, CXCL1, MAPK6, GSK3B, TIPARP, MAFF, GEM, IL6, TNFAIP3, PTGS2, ZFP36
NETPATH IL 1 PATHWAYNFKB1, IL1RN, CASP1, PELI1, MAP3K7IP2
NETPATH IL 6 PATHWAY UPGADD45B, CXCL1, CEBPB, HBEGF, MAP3K8, PDGFRA, NMI, MAFF, ZFP36, PIM1, PRDM1
MENSE HYPOXIA UPP4HA1, CLK3, PFKFB3, HK2, CEBPB, TIPARP, MAFF, ATF3, ADM, WSB1
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
AIYAR COBRA1 TARGETS UP
CORUM UBIQUITIN E3 LIGASE NFKBIA FBXW11 CUL1 SKP1A
MAHAJAN RESPONSE TO IL1A UP
WEINMANN ADAPTATION TO HYPOXIA DN
BIOCARTA IL6 PATHWAY
MASSARWEH TAMOXIFEN RESISTANCE UP
LINDGREN BLADDER CANCER CLUSTER 2B
VANHARANTA UTERINE FIBROID DN
CHUANG OXIDATIVE STRESS RESPONSE UP
NCI TNFPATHWAY
LINDSTEDT DENDRITIC CELL MATURATION B
BRUECKNER TARGETS OF MIRLET7A3 DN
RASHI RESPONSE TO IONIZING RADIATION 2
LIEN BREAST CARCINOMA METAPLASTIC VS DUCTAL UP
GRAHAM CML QUIESCENT VS NORMAL QUIESCENT DN
SESTO RESPONSE TO UV C0
LINDSTEDT DENDRITIC CELL MATURATION D
IYENGAR RESPONSE TO ADIPOCYTE FACTORS
SESTO RESPONSE TO UV C5
AMIT EGF RESPONSE 40 HELA
MILI PSEUDOPODIA CHEMOTAXIS DN
KIM WT1 TARGETS 12HR DN
NETPATH IL 7 PATHWAY UP
WANG SMARCE1 TARGETS UP
NAKAYAMA FRA2 TARGETS
MITSIADES RESPONSE TO APLIDIN UP
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
NCI DISSOLUTION OF FIBRIN CLOT
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
MARTORIATI MDM4 TARGETS FETAL LIVER UP
AGARWAL AKT PATHWAY TARGETS
HINATA NFKB TARGETS KERATINOCYTE UP
RUTELLA RESPONSE TO CSF2RB AND IL4 UP
KOKKINAKIS METHIONINE DEPRIVATION 96HR UP
MARKEY RB1 ACUTE LOF UP
REN ALVEOLAR RHABDOMYOSARCOMA DN
NCI HIF1 TFPATHWAY
AMIT EGF RESPONSE 240 MCF10A
AMIT SERUM RESPONSE 60 MCF10A
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS MAGENTA UP
HAN SATB1 TARGETS DN
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 16D DN
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY DN
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION MONOCYTE UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLUE UP
AMIT EGF RESPONSE 120 HELA
BIOCARTA RANKL PATHWAY
DANG REGULATED BY MYC DN
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS UP
GAJATE RESPONSE TO TRABECTEDIN UP
BOYAULT LIVER CANCER SUBCLASS G1 DN
SHAFFER IRF4 TARGETS IN PLASMA CELL VS MATURE B LYMPHOCYTE
PODAR RESPONSE TO ADAPHOSTIN UP
LEE LIVER CANCER E2F1 UP
WANG SMARCE1 TARGETS DN
HELLER SILENCED BY METHYLATION UP
GENTILE UV RESPONSE CLUSTER D4
GOZGIT ESR1 TARGETS DN
WOOD EBV EBNA1 TARGETS DN
SUNG METASTASIS STROMA UP
NETPATH TGFBETA RECEPTOR PATHWAY DOWN
VANTVEER BREAST CANCER ESR1 DN
BERENJENO TRANSFORMED BY RHOA UP
SASSON RESPONSE TO GONADOTROPHINS DN
PUIFFE INVASION INHIBITED BY ASCITES DN
VERHAAK AML WITH NPM1 MUTATED UP
BROCKE APOPTOSIS REVERSED BY IL6
GERY CEBP TARGETS
NCI P53DOWNSTREAMPATHWAY
SPIRA SMOKERS LUNG CANCER UP
TIAN TNF SIGNALING VIA NFKB
ZHANG PROLIFERATING VS QUIESCENT
GENTILE UV LOW DOSE UP
HUANG DASATINIB RESISTANCE UP
HINATA NFKB TARGETS FIBROBLAST UP
CHARAFE BREAST CANCER LUMINAL VS BASAL DN
MISSIAGLIA REGULATED BY METHYLATION UP
FLECHNER BIOPSY KIDNEY TRANSPLANT OK VS DONOR UP
PAPASPYRIDONOS UNSTABLE ATEROSCLEROTIC PLAQUE UP
BROWNE HCMV INFECTION 12HR UP
SESTO RESPONSE TO UV C1
CROONQUIST STROMAL STIMULATION UP
ZHANG RESPONSE TO CANTHARIDIN UP
LI WILMS TUMOR VS FETAL KIDNEY 1 UP
KINSEY TARGETS OF EWSR1 FLII FUSION DN
BLUM RESPONSE TO SALIRASIB UP
BOYLAN MULTIPLE MYELOMA C DN
KHETCHOUMIAN TRIM24 TARGETS UP
KRIGE RESPONSE TO TOSEDOSTAT 24HR UP
SEMBA FHIT TARGETS UP
HORIUCHI WTAP TARGETS UP
RUTELLA RESPONSE TO CSF2RB AND IL4 DN
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
DAVICIONI TARGETS OF PAX FOXO1 FUSIONS UP
NCI LYSOPHOSPHOLIPID PATHWAY
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS GREY DN
TURASHVILI BREAST DUCTAL CARCINOMA VS DUCTAL NORMAL DN
DER IFN BETA RESPONSE UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLACK UP
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
DIRMEIER LMP1 RESPONSE LATE UP
GILDEA METASTASIS
AMIT EGF RESPONSE 20 HELA
BASSO CD40 SIGNALING UP
BIOCARTA NTHI PATHWAY
TIAN TNF SIGNALING NOT VIA NFKB
NAGASHIMA NRG1 SIGNALING UP
MARZEC IL2 SIGNALING UP
CHIBA RESPONSE TO TSA DN
LINDGREN BLADDER CANCER CLUSTER 2A DN
BIOCARTA PPARA PATHWAY
ENK UV RESPONSE EPIDERMIS DN
ZERBINI RESPONSE TO SULINDAC UP
WANG ESOPHAGUS CANCER VS NORMAL UP
CROMER TUMORIGENESIS UP
FRIDMAN SENESCENCE UP
SASSON RESPONSE TO FORSKOLIN DN
FERRARI RESPONSE TO FENRETINIDE UP
SANA RESPONSE TO IFNG UP
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN DN
NCI NF KB IS ACTIVATED AND SIGNALS SURVIVAL
MARTINEZ RESPONSE TO TRABECTEDIN UP
ELVIDGE HIF1A AND HIF2A TARGETS DN
WU HBX TARGETS 1 UP
CHEN HOXA5 TARGETS 9HR UP
NETPATH IL 5 PATHWAY UP
RORIE TARGETS OF EWSR1 FLI1 FUSION UP
WANG RECURRENT LIVER CANCER DN
SENGUPTA NASOPHARYNGEAL CARCINOMA WITH LMP1 UP
SEKI INFLAMMATORY RESPONSE LPS UP
HOEBEKE LYMPHOID STEM CELL UP
NETPATH EGFR1 PATHWAY UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
CONCANNON APOPTOSIS BY EPOXOMICIN UP
ENGELMANN CANCER PROGENITORS UP
MURAKAMI UV RESPONSE 6HR UP
BUYTAERT PHOTODYNAMIC THERAPY STRESS UP
DACOSTA ERCC3 ALLELE XPCS VS TTD DN
WANG METHYLATED IN BREAST CANCER
SENESE HDAC1 TARGETS UP
LIU TARGETS OF VMYB VS CMYB DN
MCCLUNG CREB1 TARGETS DN
KIM WT1 TARGETS UP
REACTOME P75NTR SIGNALS VIA NFKB
ONDER CDH1 TARGETS 1 DN
NCI SMAD2 3NUCLEARPATHWAY
OSMAN BLADDER CANCER UP
HESS TARGETS OF HOXA9 AND MEIS1 DN
CROONQUIST NRAS SIGNALING UP
ELVIDGE HYPOXIA BY DMOG UP
NETPATH WNT PATHWAY UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
RUTELLA RESPONSE TO HGF UP
PRAMOONJAGO SOX4 TARGETS UP
KIM WT1 TARGETS 8HR UP
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 1
ELVIDGE HIF1A TARGETS DN
LI CISPLATIN RESISTANCE DN
LENAOUR DENDRITIC CELL MATURATION UP
SWEET LUNG CANCER KRAS UP
MUELLER COMMON TARGETS OF AML FUSIONS DN
TENEDINI MEGAKARYOCYTE MARKERS
CHEN LVAD SUPPORT OF FAILING HEART UP
HELLER HDAC TARGETS SILENCED BY METHYLATION DN
NATSUME RESPONSE TO INTERFERON BETA DN
LINDSTEDT DENDRITIC CELL MATURATION A
BASAKI YBX1 TARGETS DN
ELVIDGE HYPOXIA UP
RODRIGUES THYROID CARCINOMA ANAPLASTIC UP
NETPATH T CELL RECEPTOR PATHWAY DOWN
NETPATH TGFBETA RECEPTOR PATHWAY UP
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 5
MORI EMU MYC LYMPHOMA BY ONSET TIME DN
SESTO RESPONSE TO UV C2
BROWNE INTERFERON RESPONSIVE GENES
NCI IL6 7PATHWAY
TIEN INTESTINE PROBIOTICS 24HR DN
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINDED IN ERYTHROCYTE UP
NUYTTEN NIPP1 TARGETS UP
FRIDMAN IMMORTALIZATION DN
GENTILE UV RESPONSE CLUSTER D1
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
DAZARD UV RESPONSE CLUSTER G3
OSADA ASCL1 TARGETS DN
NUYTTEN EZH2 TARGETS UP
DUTTA APOPTOSIS VIA NFKB
TSAI RESPONSE TO IONIZING RADIATION
DELYS THYROID CANCER UP
KRISHNAN FURIN TARGETS UP
DIRMEIER LMP1 RESPONSE EARLY
LANDIS ERBB2 BREAST TUMORS 324 UP
AMIT SERUM RESPONSE 240 MCF10A
SEMENZA HIF1 TARGETS
KANG CISPLATIN RESISTANCE UP
SWEET KRAS ONCOGENIC SIGNATURE
ZHOU INFLAMMATORY RESPONSE LIVE UP
ONDER CDH1 TARGETS 3 DN
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 UP
HELLEBREKERS SILENCED DURING TUMOR ANGIOGENESIS
LU AGING BRAIN DN
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
WINTER HYPOXIA METAGENE
SAKAI CHRONIC HEPATITIS VS LIVER CANCER UP
NETPATH TNF ALPHA PATHWAY
NEWMAN ERCC6 TARGETS UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS TURQUOISE UP
TAVOR CEBPA TARGETS UP
FOSTER INFLAMMATORY RESPONSE LPS DN
LU TUMOR VASCULATURE UP
OSAWA TNF TARGETS
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
NETPATH TNF ALPHA PATHWAY UP
VETTER TARGETS OF PRKCA AND ETS1 DN
GESERICK TERT TARGETS DN
KEGG T CELL RECEPTOR SIGNALING PATHWAY
AMIT SERUM RESPONSE 120 MCF10A
BROWNE HCMV INFECTION 2HR UP
APPEL IMATINIB RESPONSE
KIM WT1 TARGETS 12HR UP
NCI IL1PATHWAY
SESTO RESPONSE TO UV C3
WAMUNYOKOLI OVARIAN CANCER GRADES 1 2 DN
GEISS RESPONSE TO DSRNA UP
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
GENTILE UV HIGH DOSE DN
SENESE HDAC2 TARGETS UP
GRUETZMANN PANCREATIC CANCER UP
JI RESPONSE TO FSH DN
NCI HIF2PATHWAY
ROZANOV MMP14 TARGETS UP
OKUMURA INFLAMMATORY RESPONSE LPS
WENDT COHESIN TARGETS UP
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
AMIT DELAYED EARLY GENES
KRIGE AMINO ACID DEPRIVATION
AMIT EGF RESPONSE 60 MCF10A
NOJIMA SFRP2 TARGETS UP
RHEIN ALL GLUCOCORTICOID THERAPY UP
CHEN HOXA5 TARGETS 6HR UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
NETPATH EGFR1 PATHWAY DOWN
LEONARD HYPOXIA
BONCI TARGETS OF MIR15A AND MIR16 1
RICKMAN TUMOR DIFFERENTIATED WELL VS MODERATELY DN
RODRIGUES THYROID CARCINOMA DN
DAZARD RESPONSE TO UV SCC UP
HALMOS CEBPA TARGETS UP
WU CELL MIGRATION
CHANDRAN METASTASIS DN
SHAFFER IRF4 TARGETS IN MYELOMA VS MATURE B LYMPHOCYTE
BEIER GLIOMA STEM CELL DN
BROWNE HCMV INFECTION 2HR DN
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN
ZHONG RESPONSE TO AZACITIDINE AND TSA UP
MAHADEVAN RESPONSE TO MP470 DN
DORN ADENOVIRUS INFECTION 12HR DN
RIGGINS TAMOXIFEN RESISTANCE DN
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D UP
HARRIS HYPOXIA
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS DN
KOKKINAKIS METHIONINE DEPRIVATION 48HR UP
CASORELLI ACUTE PROMYELOCYTIC LEUKEMIA UP
KAN RESPONSE TO ARSENIC TRIOXIDE
BHATI G2M ARREST BY 2METHOXYESTRADIOL UP
SOUCEK MYC TARGETS
DACOSTA UV RESPONSE VIA ERCC3 DN
SCHLOSSER SERUM RESPONSE DN
BILBAN B CLL LPL DN
IZADPANAH STEM CELL ADIPOSE VS BONE UP
GENTILE UV LOW DOSE DN
RASHI RESPONSE TO IONIZING RADIATION 1
ZHAN MULTIPLE MYELOMA LB DN
DACOSTA UV RESPONSE VIA ERCC3 COMMON DN
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION HSC UP
GOLDRATH ANTIGEN RESPONSE
KEGG EPITHELIAL CELL SIGNALING IN HELICOBACTER PYLORI INFECTION
SHAFFER IRF4 MULTIPLE MYELOMA PROGRAM
BILD HRAS ONCOGENIC SIGNATURE
FLECHNER PBL KIDNEY TRANSPLANT OK VS DONOR DN
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
DER IFN ALPHA RESPONSE UP
RUTELLA RESPONSE TO HGF DN
BERENJENO TRANSFORMED BY RHOA FOREVER DN
AMIT EGF RESPONSE 60 HELA
ADDYA ERYTHROID DIFFERENTIATION BY HEMIN
DAZARD UV RESPONSE CLUSTER G2
LEE SP4 THYMOCYTE
AMUNDSON RESPONSE TO ARSENITE
WATANABE RECTAL CANCER RADIOTHERAPY RESPONSIVE DN
AMIT SERUM RESPONSE 40 MCF10A
HELLER HDAC TARGETS SILENCED BY METHYLATION UP
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
HELLER SILENCED BY METHYLATION DN
BIERIE INFLAMMATORY RESPONSE TGFB1
SANA TNF SIGNALING UP
THUM SYSTOLIC HEART FAILURE UP
SCHUETZ BREAST CANCER DUCTAL INVASIVE UP
SENESE HDAC1 AND HDAC2 TARGETS UP
ONDER CDH1 TARGETS 2 DN
AMIT EGF RESPONSE 240 HELA
MANALO HYPOXIA UP
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
UDAYAKUMAR MED1 TARGETS DN
SENESE HDAC3 TARGETS UP
SHAFFER IRF4 TARGETS IN ACTIVATED B LYMPHOCYTE
KRIGE RESPONSE TO TOSEDOSTAT 6HR UP
VECCHI GASTRIC CANCER ADVANCED VS EARLY UP
NETPATH ANDROGEN RECEPTOR PATHWAY UP
CHARAFE BREAST CANCER LUMINAL VS MESENCHYMAL DN
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
XU HGF SIGNALING NOT VIA AKT1 6HR
JISON SICKLE CELL DISEASE UP
NCI NFKAPPABCANONICALPATHWAY
XU HGF SIGNALING NOT VIA AKT1 48HR UP
DASU IL6 SIGNALING UP
NETPATH IL 2 PATHWAY UP
HELLER HDAC TARGETS DN
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
ZUCCHI METASTASIS DN
BRUECKNER TARGETS OF MIRLET7A3 UP
DEURIG T CELL PROLYMPHOCYTIC LEUKEMIA DN
DAZARD RESPONSE TO UV SCC DN
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
yersinia enterocolitica wap bcstreptococcus pneumoniae g54listeria monocytogenesGeneSet Name
0.00001 0.02186 0.00000NETPATH_IL_1_PATHWAY_UP
0.00000 0.00809 0.00007NETPATH_TNF_ALPHA_PATHWAY_DOWN
0.00093 0.03624 0.00142NETPATH_IL_1_PATHWAY
0.00000 0.01842 0.00233NETPATH_IL_6_PATHWAY_UP
0.00167 0.00004 0.01410MENSE_HYPOXIA_UP
0.00000 0.03257 0.00023GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.08469 0.10601 0.19105AIYAR_COBRA1_TARGETS_UP
0.15117 0.13876 0.16771CORUM_UBIQUITIN_E3_LIGASE_NFKBIA_FBXW11_CUL1_SKP1A
0.00000 0.08911 0.00046MAHAJAN_RESPONSE_TO_IL1A_UP
0.00001 0.00875 0.01186WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.17070 0.06093 0.05350BIOCARTA_IL6_PATHWAY
0.03413 0.00108 0.18363MASSARWEH_TAMOXIFEN_RESISTANCE_UP
0.00193 0.08248 0.06578LINDGREN_BLADDER_CANCER_CLUSTER_2B
0.00193 0.00677 0.01117VANHARANTA_UTERINE_FIBROID_DN
0.05875 0.12323 0.00900CHUANG_OXIDATIVE_STRESS_RESPONSE_UP
0.19256 0.16078 0.03361NCI_TNFPATHWAY
0.00004 0.00817 0.00437LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.00784 0.00199 0.02119BRUECKNER_TARGETS_OF_MIRLET7A3_DN
0.00001 0.00271 0.04054RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.01065 0.04813 0.00043LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.01664 0.09379 0.00481GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN
0.04270 0.00808 0.00001SESTO_RESPONSE_TO_UV_C0
0.00297 0.08206 0.00104LINDSTEDT_DENDRITIC_CELL_MATURATION_D
0.06007 0.03272 0.01417IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.02962 0.00055 0.14882SESTO_RESPONSE_TO_UV_C5
0.00018 0.02615 0.00068AMIT_EGF_RESPONSE_40_HELA
0.09298 0.02913 0.17654MILI_PSEUDOPODIA_CHEMOTAXIS_DN
0.04401 0.06314 0.10987KIM_WT1_TARGETS_12HR_DN
0.00052 0.11486 0.09197NETPATH_IL_7_PATHWAY_UP
0.13917 0.00621 0.12445WANG_SMARCE1_TARGETS_UP
0.02768 0.14370 0.04498NAKAYAMA_FRA2_TARGETS
0.00513 0.00669 0.00418MITSIADES_RESPONSE_TO_APLIDIN_UP
0.00000 0.09013 0.00000THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.06009 0.12100 0.17554NCI_DISSOLUTION_OF_FIBRIN_CLOT
0.00012 0.13995 0.00008TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.07895 0.07515 0.08063MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
0.03174 0.18895 0.06344AGARWAL_AKT_PATHWAY_TARGETS
0.00000 0.00568 0.00001HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.04366 0.00276 0.04075RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
0.00372 0.02436 0.12454KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.00001 0.10730 0.00004MARKEY_RB1_ACUTE_LOF_UP
0.02963 0.00269 0.00307REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
0.03883 0.10049 0.00889NCI_HIF1_TFPATHWAY
0.00206 0.03825 0.19588AMIT_EGF_RESPONSE_240_MCF10A
0.00000 0.00321 0.02234AMIT_SERUM_RESPONSE_60_MCF10A
0.00313 0.00558 0.00178GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP
0.00178 0.04828 0.00346HAN_SATB1_TARGETS_DN
0.02001 0.10702 0.02652TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
0.00439 0.00390 0.00003RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
0.00152 0.09373 0.02666TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
0.00000 0.01216 0.00000GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.00000 0.01466 0.02592AMIT_EGF_RESPONSE_120_HELA
0.02104 0.11238 0.17317BIOCARTA_RANKL_PATHWAY
0.00106 0.07999 0.01850DANG_REGULATED_BY_MYC_DN
0.00178 0.00715 0.01810FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
0.00903 0.00696 0.01700GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.11023 0.01330 0.02770BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN
0.00007 0.03041 0.01078SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.00000 0.00016 0.00004PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.00205 0.05639 0.02021LEE_LIVER_CANCER_E2F1_UP
0.05349 0.03606 0.04978WANG_SMARCE1_TARGETS_DN
0.00040 0.17361 0.07324HELLER_SILENCED_BY_METHYLATION_UP
0.09957 0.03854 0.02662GENTILE_UV_RESPONSE_CLUSTER_D4
0.01073 0.03000 0.03343GOZGIT_ESR1_TARGETS_DN
0.12526 0.04965 0.00309WOOD_EBV_EBNA1_TARGETS_DN
0.01811 0.00325 0.19028SUNG_METASTASIS_STROMA_UP
0.03066 0.14788 0.05923NETPATH_TGFBETA_RECEPTOR_PATHWAY_DOWN
0.06676 0.05316 0.02711VANTVEER_BREAST_CANCER_ESR1_DN
0.01221 0.09492 0.13680BERENJENO_TRANSFORMED_BY_RHOA_UP
0.00120 0.10101 0.15021SASSON_RESPONSE_TO_GONADOTROPHINS_DN
0.12153 0.00111 0.00272PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN
0.00000 0.12533 0.00000VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.00001 0.09635 0.00001BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.00013 0.12493 0.00163GERY_CEBP_TARGETS
0.01652 0.06541 0.14599NCI_P53DOWNSTREAMPATHWAY
0.14413 0.02072 0.07678SPIRA_SMOKERS_LUNG_CANCER_UP
0.00000 0.16057 0.00054TIAN_TNF_SIGNALING_VIA_NFKB
0.00740 0.14796 0.12224ZHANG_PROLIFERATING_VS_QUIESCENT
0.00750 0.16976 0.00488GENTILE_UV_LOW_DOSE_UP
0.00025 0.00242 0.07424HUANG_DASATINIB_RESISTANCE_UP
0.00001 0.02432 0.00031HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.00007 0.00034 0.00002CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
0.00107 0.00810 0.00001MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.10764 0.00583 0.02746FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
0.13142 0.10854 0.00010PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP
0.05709 0.10890 0.12016BROWNE_HCMV_INFECTION_12HR_UP
0.02108 0.00828 0.00001SESTO_RESPONSE_TO_UV_C1
0.00829 0.09861 0.05925CROONQUIST_STROMAL_STIMULATION_UP
0.09898 0.03275 0.17841ZHANG_RESPONSE_TO_CANTHARIDIN_UP
0.01741 0.00449 0.03312LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
0.01070 0.00396 0.15145KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
0.01324 0.00392 0.03125BLUM_RESPONSE_TO_SALIRASIB_UP
0.02924 0.10863 0.15341BOYLAN_MULTIPLE_MYELOMA_C_DN
0.02929 0.02156 0.10702KHETCHOUMIAN_TRIM24_TARGETS_UP
0.03027 0.00388 0.03361KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
0.15488 0.12289 0.05071SEMBA_FHIT_TARGETS_UP
0.00023 0.00695 0.01805HORIUCHI_WTAP_TARGETS_UP
0.00040 0.03089 0.00000RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.00124 0.02167 0.07558CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.00132 0.00923 0.09180DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
0.10752 0.17451 0.00321NCI_LYSOPHOSPHOLIPID_PATHWAY
0.07894 0.03664 0.00654GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN
0.17539 0.01840 0.12603TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.00563 0.11870 0.00000DER_IFN_BETA_RESPONSE_UP
0.01076 0.07134 0.00166GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP
0.00012 0.01803 0.00000DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.00001 0.06964 0.12444DIRMEIER_LMP1_RESPONSE_LATE_UP
0.11098 0.10751 0.14957GILDEA_METASTASIS
0.06004 0.04591 0.02894AMIT_EGF_RESPONSE_20_HELA
0.00000 0.03498 0.00020BASSO_CD40_SIGNALING_UP
0.02315 0.04158 0.03739BIOCARTA_NTHI_PATHWAY
0.00034 0.00388 0.01298TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.00000 0.00022 0.00045NAGASHIMA_NRG1_SIGNALING_UP
0.00006 0.16651 0.00507MARZEC_IL2_SIGNALING_UP
0.07820 0.17824 0.04833CHIBA_RESPONSE_TO_TSA_DN
0.09740 0.00638 0.07490LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
0.00401 0.18979 0.13158BIOCARTA_PPARA_PATHWAY
0.00120 0.00387 0.00904ENK_UV_RESPONSE_EPIDERMIS_DN
0.16203 0.09092 0.05033ZERBINI_RESPONSE_TO_SULINDAC_UP
0.01616 0.10110 0.17037WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.01752 0.02045 0.01616CROMER_TUMORIGENESIS_UP
0.01642 0.03706 0.15020FRIDMAN_SENESCENCE_UP
0.00301 0.16936 0.04182SASSON_RESPONSE_TO_FORSKOLIN_DN
0.00007 0.01205 0.06128FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.00025 0.15101 0.00000SANA_RESPONSE_TO_IFNG_UP
0.00001 0.02602 0.05104ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.11013 0.17477 0.07063NCI_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL
0.01028 0.05063 0.00555MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP
0.05224 0.00054 0.00371ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
0.00334 0.07559 0.08533WU_HBX_TARGETS_1_UP
0.00001 0.00050 0.00000CHEN_HOXA5_TARGETS_9HR_UP
0.00001 0.07746 0.00007NETPATH_IL_5_PATHWAY_UP
0.01326 0.04298 0.00899RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.00893 0.05148 0.03753WANG_RECURRENT_LIVER_CANCER_DN
0.04179 0.08290 0.01005SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
0.00000 0.02093 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.09702 0.00034 0.16214HOEBEKE_LYMPHOID_STEM_CELL_UP
0.00014 0.11210 0.03270NETPATH_EGFR1_PATHWAY_UP
0.00008 0.11160 0.00097GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.00014 0.01005 0.00060CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.03824 0.00380 0.00527ENGELMANN_CANCER_PROGENITORS_UP
0.00258 0.16966 0.07302MURAKAMI_UV_RESPONSE_6HR_UP
0.00019 0.00031 0.00000BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
0.01079 0.06987 0.19955DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN
0.00001 0.02474 0.17968WANG_METHYLATED_IN_BREAST_CANCER
0.00001 0.05349 0.00009SENESE_HDAC1_TARGETS_UP
0.03136 0.15815 0.05670LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.15969 0.16798 0.19541MCCLUNG_CREB1_TARGETS_DN
0.00000 0.00273 0.01564KIM_WT1_TARGETS_UP
0.15860 0.13024 0.02184REACTOME_P75NTR_SIGNALS_VIA_NFKB
0.00277 0.07758 0.00003ONDER_CDH1_TARGETS_1_DN
0.07276 0.02286 0.08522NCI_SMAD2_3NUCLEARPATHWAY
0.10501 0.03886 0.02362OSMAN_BLADDER_CANCER_UP
0.00000 0.13868 0.00001HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.18291 0.17404 0.08123CROONQUIST_NRAS_SIGNALING_UP
0.00045 0.00018 0.00142ELVIDGE_HYPOXIA_BY_DMOG_UP
0.01134 0.14364 0.01903NETPATH_WNT_PATHWAY_UP
0.00000 0.01851 0.00001OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.00232 0.00850 0.00007RUTELLA_RESPONSE_TO_HGF_UP
0.00024 0.00000 0.01526PRAMOONJAGO_SOX4_TARGETS_UP
0.00153 0.01014 0.00699KIM_WT1_TARGETS_8HR_UP
0.00000 0.00267 0.00887PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.04480 0.07009 0.06387YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.06497 0.00071 0.00409ELVIDGE_HIF1A_TARGETS_DN
0.09993 0.04065 0.16854LI_CISPLATIN_RESISTANCE_DN
0.01066 0.09690 0.16194LENAOUR_DENDRITIC_CELL_MATURATION_UP
0.04437 0.07052 0.03943SWEET_LUNG_CANCER_KRAS_UP
0.01376 0.13820 0.03122MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
0.07725 0.11247 0.09679TENEDINI_MEGAKARYOCYTE_MARKERS
0.00011 0.01145 0.06346CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.00970 0.09151 0.07889HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
0.17049 0.04185 0.00001NATSUME_RESPONSE_TO_INTERFERON_BETA_DN
0.00000 0.16372 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.09449 0.00152 0.19970BASAKI_YBX1_TARGETS_DN
0.00006 0.00034 0.00023ELVIDGE_HYPOXIA_UP
0.06197 0.02036 0.00201RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
0.10216 0.09456 0.01903NETPATH_T_CELL_RECEPTOR_PATHWAY_DOWN
0.01876 0.03675 0.07219NETPATH_TGFBETA_RECEPTOR_PATHWAY_UP
0.01552 0.03309 0.15820YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.00542 0.09386 0.13545MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN
0.07893 0.01362 0.00026SESTO_RESPONSE_TO_UV_C2
0.00000 0.11107 0.00000BROWNE_INTERFERON_RESPONSIVE_GENES
0.08946 0.10802 0.03989NCI_IL6_7PATHWAY
0.03871 0.00936 0.01129TIEN_INTESTINE_PROBIOTICS_24HR_DN
0.02964 0.14828 0.00030TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.03424 0.00315 0.00090NUYTTEN_NIPP1_TARGETS_UP
0.11302 0.07577 0.16402FRIDMAN_IMMORTALIZATION_DN
0.00086 0.19995 0.07054GENTILE_UV_RESPONSE_CLUSTER_D1
0.00000 0.17463 0.00736KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.04407 0.03860 0.00837DAZARD_UV_RESPONSE_CLUSTER_G3
0.08630 0.03295 0.04416OSADA_ASCL1_TARGETS_DN
0.00008 0.00276 0.00000NUYTTEN_EZH2_TARGETS_UP
0.00003 0.05455 0.01422DUTTA_APOPTOSIS_VIA_NFKB
0.05125 0.03105 0.13958TSAI_RESPONSE_TO_IONIZING_RADIATION
0.01537 0.05377 0.05915DELYS_THYROID_CANCER_UP
0.13352 0.11205 0.04616KRISHNAN_FURIN_TARGETS_UP
0.00000 0.08905 0.00199DIRMEIER_LMP1_RESPONSE_EARLY
0.05187 0.04149 0.19059LANDIS_ERBB2_BREAST_TUMORS_324_UP
0.02292 0.01938 0.00207AMIT_SERUM_RESPONSE_240_MCF10A
0.04194 0.17257 0.00011SEMENZA_HIF1_TARGETS
0.04257 0.08920 0.09697KANG_CISPLATIN_RESISTANCE_UP
0.14174 0.02469 0.02543SWEET_KRAS_ONCOGENIC_SIGNATURE
0.00000 0.11282 0.00000ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.01083 0.03102 0.00011ONDER_CDH1_TARGETS_3_DN
0.00121 0.01828 0.00000RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
0.00401 0.16628 0.16188HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
0.13630 0.00736 0.07262LU_AGING_BRAIN_DN
0.00012 0.13119 0.01127NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.00004 0.01549 0.00186WINTER_HYPOXIA_METAGENE
0.05849 0.05988 0.00098SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP
0.12395 0.02401 0.08032NETPATH_TNF_ALPHA_PATHWAY
0.01325 0.04821 0.09674NEWMAN_ERCC6_TARGETS_UP
0.00000 0.01570 0.00001GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.01106 0.04868 0.00125TAVOR_CEBPA_TARGETS_UP
0.00000 0.01680 0.00001FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.07044 0.16618 0.01828LU_TUMOR_VASCULATURE_UP
0.05837 0.00719 0.05254OSAWA_TNF_TARGETS
0.03490 0.02405 0.03199SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.01532 0.07319 0.00123NETPATH_TNF_ALPHA_PATHWAY_UP
0.11984 0.17444 0.08791VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN
0.00000 0.00310 0.02216GESERICK_TERT_TARGETS_DN
0.06911 0.17024 0.14664KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
0.00000 0.00320 0.00040AMIT_SERUM_RESPONSE_120_MCF10A
0.02213 0.04469 0.02059BROWNE_HCMV_INFECTION_2HR_UP
0.03154 0.04083 0.00873APPEL_IMATINIB_RESPONSE
0.03004 0.00441 0.16372KIM_WT1_TARGETS_12HR_UP
0.00841 0.18632 0.00886NCI_IL1PATHWAY
0.00406 0.01104 0.00002SESTO_RESPONSE_TO_UV_C3
0.14246 0.05027 0.01960WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN
0.00000 0.03258 0.00027GEISS_RESPONSE_TO_DSRNA_UP
0.00011 0.03598 0.00032GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.01077 0.00382 0.00602GENTILE_UV_HIGH_DOSE_DN
0.00006 0.12202 0.00878SENESE_HDAC2_TARGETS_UP
0.00480 0.00920 0.00031GRUETZMANN_PANCREATIC_CANCER_UP
0.10591 0.06935 0.02714JI_RESPONSE_TO_FSH_DN
0.00562 0.06914 0.12558NCI_HIF2PATHWAY
0.03703 0.08267 0.05511ROZANOV_MMP14_TARGETS_UP
0.01782 0.04102 0.00777OKUMURA_INFLAMMATORY_RESPONSE_LPS
0.10759 0.04100 0.19444WENDT_COHESIN_TARGETS_UP
0.00193 0.06587 0.02848LEE_LIVER_CANCER_HEPATOBLAST
0.00000 0.00045 0.00001NAGASHIMA_EGF_SIGNALING_UP
0.00156 0.01300 0.00200AMIT_DELAYED_EARLY_GENES
0.00024 0.04467 0.15378KRIGE_AMINO_ACID_DEPRIVATION
0.00000 0.00090 0.01523AMIT_EGF_RESPONSE_60_MCF10A
0.00224 0.17017 0.02668NOJIMA_SFRP2_TARGETS_UP
0.04368 0.05094 0.00045RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.01068 0.01846 0.00069CHEN_HOXA5_TARGETS_6HR_UP
0.00133 0.01189 0.00015SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.00000 0.01878 0.00001OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.00753 0.04385 0.05099NETPATH_EGFR1_PATHWAY_DOWN
0.00652 0.00548 0.00328LEONARD_HYPOXIA
0.00451 0.02165 0.18772BONCI_TARGETS_OF_MIR15A_AND_MIR16_1
0.02849 0.04752 0.02472RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN
0.00696 0.02448 0.00235RODRIGUES_THYROID_CARCINOMA_DN
0.02062 0.01405 0.04954DAZARD_RESPONSE_TO_UV_SCC_UP
0.00154 0.02527 0.01542HALMOS_CEBPA_TARGETS_UP
0.09748 0.00050 0.00267WU_CELL_MIGRATION
0.04629 0.15824 0.06255CHANDRAN_METASTASIS_DN
0.00393 0.02411 0.06270SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
0.14349 0.00652 0.16622BEIER_GLIOMA_STEM_CELL_DN
0.03861 0.09008 0.05613BROWNE_HCMV_INFECTION_2HR_DN
0.01934 0.04993 0.00298GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.03095 0.09090 0.05928ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
0.00006 0.15502 0.01146MAHADEVAN_RESPONSE_TO_MP470_DN
0.09384 0.10988 0.00201DORN_ADENOVIRUS_INFECTION_12HR_DN
0.05427 0.00460 0.03786RIGGINS_TAMOXIFEN_RESISTANCE_DN
0.00000 0.08161 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.00004 0.10031 0.00000HARRIS_HYPOXIA
0.00000 0.12500 0.00000FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
0.00057 0.02323 0.04308KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.00233 0.04079 0.08045CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
0.00286 0.04440 0.00399KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.05326 0.12316 0.00283BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP
0.00001 0.08229 0.09270SOUCEK_MYC_TARGETS
0.00196 0.00135 0.03426DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
0.10872 0.00395 0.02650SCHLOSSER_SERUM_RESPONSE_DN
0.00001 0.05066 0.01132BILBAN_B_CLL_LPL_DN
0.12181 0.04689 0.00386IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.00814 0.17440 0.00587GENTILE_UV_LOW_DOSE_DN
0.07395 0.02099 0.01976RASHI_RESPONSE_TO_IONIZING_RADIATION_1
0.00337 0.08960 0.00177ZHAN_MULTIPLE_MYELOMA_LB_DN
0.00995 0.00318 0.06466DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
0.14423 0.02403 0.05738TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
0.01073 0.18885 0.04561GOLDRATH_ANTIGEN_RESPONSE
0.09896 0.07363 0.02896KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION
0.00219 0.09034 0.00105SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
0.00000 0.00093 0.00000BILD_HRAS_ONCOGENIC_SIGNATURE
0.19414 0.11804 0.01138FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
0.00007 0.01216 0.00001LIANG_SILENCED_BY_METHYLATION_2
0.06147 0.03237 0.00016DAUER_STAT3_TARGETS_UP
0.01898 0.11860 0.00000DER_IFN_ALPHA_RESPONSE_UP
0.01776 0.00674 0.05674RUTELLA_RESPONSE_TO_HGF_DN
0.00000 0.02282 0.03353BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.00000 0.02905 0.02795AMIT_EGF_RESPONSE_60_HELA
0.00197 0.09462 0.03814ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.00772 0.03619 0.04745DAZARD_UV_RESPONSE_CLUSTER_G2
0.07837 0.15653 0.06132LEE_SP4_THYMOCYTE
0.16537 0.00551 0.00211AMUNDSON_RESPONSE_TO_ARSENITE
0.12726 0.05398 0.15455WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
0.00000 0.00737 0.00799AMIT_SERUM_RESPONSE_40_MCF10A
0.01551 0.07822 0.06392HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
0.00000 0.00231 0.00000ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.00072 0.18318 0.07386HELLER_SILENCED_BY_METHYLATION_DN
0.00509 0.05057 0.05971BIERIE_INFLAMMATORY_RESPONSE_TGFB1
0.00000 0.15203 0.00000SANA_TNF_SIGNALING_UP
0.09118 0.19736 0.00980THUM_SYSTOLIC_HEART_FAILURE_UP
0.00001 0.13731 0.00306SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
0.00001 0.15156 0.00023SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.00111 0.00297 0.00554ONDER_CDH1_TARGETS_2_DN
0.00000 0.08012 0.00272AMIT_EGF_RESPONSE_240_HELA
0.09991 0.00075 0.17900MANALO_HYPOXIA_UP
0.00000 0.00067 0.00000HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.00944 0.00081 0.09209UDAYAKUMAR_MED1_TARGETS_DN
0.00001 0.03264 0.00256SENESE_HDAC3_TARGETS_UP
0.02098 0.03773 0.18617SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
0.05235 0.00782 0.17966KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
0.04442 0.01922 0.00309VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
0.08205 0.00513 0.03984NETPATH_ANDROGEN_RECEPTOR_PATHWAY_UP
0.00145 0.00112 0.00737CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
0.00000 0.00000 0.00007UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.00157 0.06148 0.00146XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.00072 0.04179 0.00000JISON_SICKLE_CELL_DISEASE_UP
0.00132 0.05639 0.01014NCI_NFKAPPABCANONICALPATHWAY
0.00258 0.08775 0.00850XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.00001 0.09369 0.00595DASU_IL6_SIGNALING_UP
0.00010 0.16635 0.00068NETPATH_IL_2_PATHWAY_UP
0.01757 0.17928 0.03349HELLER_HDAC_TARGETS_DN
0.00000 0.03864 0.00001GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.00010 0.01824 0.00518ZUCCHI_METASTASIS_DN
0.00513 0.00087 0.00484BRUECKNER_TARGETS_OF_MIRLET7A3_UP
0.09111 0.01586 0.00107DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
0.18783 0.00931 0.04078DAZARD_RESPONSE_TO_UV_SCC_DN